Briacell Therapeutics Corp Stock Analysis

Briacell Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.89. Briacell Therapeutics last dividend was issued on the 2nd of January 2020. The entity had 1:300 split on the 2nd of January 2020. BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada. BriaCell Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Briacell Therapeutics Corp please contact William MD at 604-921-1810 or go to https://briacell.com.

Briacell Therapeutics Investment Alerts

Briacell Therapeutics Upcoming and Recent Events

Briacell Largest EPS Surprises

View All Earnings Estimates

Briacell Stock Institutional Investors

Note, although Briacell Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Briacell Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.47 M.

Briacell Profitablity

Management Efficiency

Briacell Therapeutics has return on total asset (ROA) of (1.2611) % which means that it has lost $1.2611 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0601) %, meaning that it created substantial loss on money invested by shareholders. Briacell Therapeutics' management efficiency ratios could be used to measure how well Briacell Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 5.08 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.64). At this time, Briacell Therapeutics' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.2 M in 2024.

Technical Drivers

As of the 23rd of December, Briacell Therapeutics shows the Mean Deviation of 8.38, risk adjusted performance of 0.0521, and Downside Deviation of 11.02. Briacell Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Briacell Therapeutics Price Movement Analysis

Briacell Therapeutics Insider Trading Activities

Briacell Therapeutics Outstanding Bonds

Briacell Therapeutics Predictive Daily Indicators

Briacell Therapeutics Forecast Models

Briacell Therapeutics' time-series forecasting models are one of many Briacell Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Briacell Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Briacell Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Briacell shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Briacell Therapeutics. By using and applying Briacell Stock analysis, traders can create a robust methodology for identifying Briacell entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Briacell analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Briacell analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Briacell Therapeutics Corp stock analysis indicators help investors evaluate how Briacell Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Briacell Therapeutics shares will generate the highest return on investment. By understating and applying Briacell Therapeutics stock analysis, traders can identify Briacell Therapeutics position entry and exit signals to maximize returns.

When running Briacell Therapeutics' price analysis, check to measure Briacell Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Briacell Therapeutics is operating at the current time. Most of Briacell Therapeutics' value examination focuses on studying past and present price action to predict the probability of Briacell Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Briacell Therapeutics' price. Additionally, you may evaluate how the addition of Briacell Therapeutics to your portfolios can decrease your overall portfolio volatility.